$AIZ

Do Wall Street Analysts Like Assurant Stock?

Assurant (AIZ) stock has risen 34.7% over the past year, outperforming the S&P 500. Q2 2026 revenue was $3.5B, up 6.9% YoY, with adjusted EPS of $6.41. Analysts expect 11.5% EPS growth for the year. Nine analysts rate it 'Strong Buy,' with a mean price target of $321.43, implying 11.4% upside.

Original reporting
Published Aug 28, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 7:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Do Wall Street Analysts Like Assurant Stock? — source image
Decision brief

The 30-second read

$AIZBullishMed
01

Why it matters

The earnings beat and target raise reinforce a bullish outlook, but valuation concerns remain.

02

Market read

Assurant's earnings beat supports a positive bias for the insurance sector and may attract momentum traders.

03

What to watch

Potential regulatory scrutiny on insurance pricing and macro‑economic headwinds could curb growth.

Relevance 8/10Novelty 8/10Timing: post‑earnings Aug 5

Background

Assurant provides protection services for devices, homes, and automobiles, reporting a strong Q2 2026 performance.

Company-level read

Ticker impact

$AIZBullishHigh confidence
Context

Q2 2026 earnings beat expectations; revenue $3.5B, EPS $6.41, stock rose 7.2% on Aug 5 and price target raised to $320.

Expected impact

Potential further 5-10% rally over the next week if momentum holds.

Evidence & confidence

Strong earnings beat, analyst consensus remains Strong Buy, and target raise indicate bullish sentiment.

Market effects

Positive earnings may lift the insurance and protection services sector.

U.S. insurers could see modest inflows as investors seek defensive growth stocks.

Assurant's international exposure adds a global dimension to its earnings beat.

Counterpoint

The stock's recent run may be overvalued; price targets still below current price, limiting upside.

Key entities

  • Assurant, Inc.

    U.S. insurer with market cap $14.1B, ticker AIZ.

  • Morgan Stanley

    Raised Assurant price target to $320 on Aug 19.

Related articles

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.